This spontaneous case was reported by a consumer and describes the occurrence of AMYOTROPHY (neurologic amyotrophy) and DIPLEGIA (my hand froze up to a paralysis/My hand was like spastic frozen or whatever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood disorder NOS (Patient mentioned to have a generic blood disorder.) and Heart disease, unspecified (Patient mentioned to have a heart issues.). Concomitant products included TRIENTINE for an unknown indication.    On 19-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Oct-2021, the patient experienced MOBILITY DECREASED (I cannot move my hand, cannot raise my hand above my shoulder), HYPOAESTHESIA (From the top of my shoulder down to my shoulder blade  is an achy numb feeling), TOOTHACHE (My teeth hurt), EAR PAIN (My left ear hurts), FACIAL PAIN (total left side of my face hurts/left cheek hurts) and NECK PAIN (left side of my neck hurts). On an unknown date, the patient experienced AMYOTROPHY (neurologic amyotrophy) (seriousness criterion medically significant), DIPLEGIA (my hand froze up to a paralysis/My hand was like spastic frozen or whatever) (seriousness criterion medically significant), HIP FRACTURE (I broke my hip), PERIPHERAL COLDNESS (my fingers were all white and ice cold up my arm, shoulder and neck, and to the left side of my face) and MYALGIA (My arm was really sore). At the time of the report, AMYOTROPHY (neurologic amyotrophy), DIPLEGIA (my hand froze up to a paralysis/My hand was like spastic frozen or whatever), HIP FRACTURE (I broke my hip), MOBILITY DECREASED (I cannot move my hand, cannot raise my hand above my shoulder), HYPOAESTHESIA (From the top of my shoulder down to my shoulder blade  is an achy numb feeling), TOOTHACHE (My teeth hurt), EAR PAIN (My left ear hurts), FACIAL PAIN (total left side of my face hurts/left cheek hurts), NECK PAIN (left side of my neck hurts) and MYALGIA (My arm was really sore) outcome was unknown and PERIPHERAL COLDNESS (my fingers were all white and ice cold up my arm, shoulder and neck, and to the left side of my face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported that, "I went to the doctor after because I broke my hip, and when he touched my arm it became white again".   Patient reported that she have absolutely no intention of getting the second shot.  No treatment information  were reported.  Company comment -This case concerns a 62-year-old female patient with a history of a blood disorder (unspecified) and heart disease (unspecified), who experienced the unexpected, serious (medically significant) events of amyotrophy and diplegia. The events occurred immediately after the first dose administration and persist after 2 months and 13 days after the first dose of mRNA-1273. The rechallenge was unknown since the patient did not receive the second dose of the vaccine. The medical history blood disorder (unspecified) and heart disease (unspecified) could be confounders. The benefit-risk relationship of mRNA-1273 is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 07-Oct-2021: Significant Follow up received and contains additional reporter information, patient age and additional events like mobility decreased, hypoaesthesia, toothache, neck pain, ear pain, facial pain and condition aggravated were added.; Sender's Comments: This case concerns a 62-year-old female patient with a history of a blood disorder (unspecified) and heart disease (unspecified), who experienced the unexpected, serious (medically significant) events of amyotrophy and diplegia. The events occurred immediately after the first dose administration and persist after 2 months and 13 days after the first dose of mRNA-1273. The rechallenge was unknown since the patient did not receive the second dose of the vaccine. The medical history blood disorder (unspecified) and heart disease (unspecified) could be confounders. The benefit-risk relationship of mRNA-1273 is not affected by this report.